Início  /   The modified Glasgow prognostic score in prostate cancer: results from a retrospective clinical series of 744 patients

The modified Glasgow prognostic score in prostate cancer: results from a retrospective clinical series of 744 patients


As the incidence of prostate cancer continues to rise steeply, there is an increasing need to identify more accurate prognostic markers for the disease. There is some evidence that a higher modified Glasgow Prognostic Score (mGPS) may be associated with poorer survival in patients with prostate cancer but it is not known whether this is independent of other established prognostic factors. Therefore the aim of this study was to describe the relationship between mGPS and survival in patients with prostate cancer after adjustment for other prognostic factors.